1. Fang, Q., et al., Expression and clinical significance of miR-210 in the serum of patients with colorectal cancer. Journal of Shandong University (Health Sciences), 2015. 53: p. 77-81.
2. Jemal, A., et al., Cancer statistics. Ca Cancer J Clin, 2009. 59(4).
3. Luo, X., et al., MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiology and Prevention Biomarkers, 2011. 20(7): p. 1272-1286.
4. Siegel, R., D. Naishadham, and A. Jemal, Cancer statistics for hispanics/latinos, 2012. CA: a cancer journal for clinicians, 2012. 62(5): p. 283-298.
5. Hamada, T., R. Nishihara, and S. Ogino, Post-colonoscopy colorectal cancer: the key role of molecular pathological epidemiology. Translational gastroenterology and hepatology, 2017. 2.
6. Anvarnia, A., et al., Dysregulated microRNAs in colorectal carcinogenesis: new insight to cell survival and apoptosis regulation. Journal of cellular physiology, 2019. 234(12): p. 21683-21693.
7. Asadi, M., et al., Transcript level of MicroRNA processing elements in gastric cancer. Journal of gastrointestinal cancer, 2019. 50(4): p. 855-859.
8. Fang, Z., et al., Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Journal of experimental & clinical cancer research, 2015. 34(1): p. 1-10.
9. Mosher, C.E., et al., Associations between lifestyle factors and quality of life among older long‐term breast, prostate, and colorectal cancer survivors. Cancer: Interdisciplinary International Journal of the American Cancer Society, 2009. 115(17): p. 4001-4009.
10. Sun, Y., et al., Examining plasma microRNA markers for colorectal cancer at different stages. Oncotarget, 2016. 7(10): p. 11434.
11. Wang, S., et al., A plasma microRNA panel for early detection of colorectal cancer. International journal of cancer, 2015. 136(1): p. 152-161.
12. Reinhart, B.J., et al., The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. nature, 2000. 403(6772): p. 901-906.
13. Mizuno, R., K. Kawada, and Y. Sakai, The molecular basis and therapeutic potential of Let-7 microRNAs against colorectal cancer. Canadian Journal of Gastroenterology and Hepatology, 2018. 2018.
14. Hormones, E. and B.C.C. Group, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute, 2002. 94(8): p. 606-616.
15. Luo, X., et al., Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PloS one, 2013. 8(5): p. e62880.
16. Wang, B., et al., miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial–mesenchymal transition. Cell death & disease, 2014. 5(7): p. e1335-e1335.
17. Asangani, I.A., et al., MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008. 27(15): p. 2128-2136.
18. Meng, F., et al., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007. 133(2): p. 647-658.
19. Zhu, S., et al., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). Journal of Biological Chemistry, 2007. 282(19): p. 14328-14336.
20. Kulda, V., et al., Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer genetics and cytogenetics, 2010. 200(2): p. 154-160.
21. Nielsen, B.S., et al., High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clinical & experimental metastasis, 2011. 28(1): p. 27-38.
22. Schetter, A.J., et al., MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama, 2008. 299(4): p. 425-436.
23. Shibuya, H., et al., Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology, 2010. 79(3-4): p. 313-320.
24. Asaga, S., et al., Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clinical chemistry, 2011. 57(1): p. 84-91.
25. Kanaan, Z., et al., Plasma miR-21: a potential diagnostic marker of colorectal cancer. Annals of surgery, 2012. 256(3): p. 544-551.
26. Zarredar, H., et al., Terminalia Catappa Extract (TCE) Reduces Proliferation of Lung and Breast Cancer Cell by Modulating miR-21 and miR-34a Expressions. Asian Pacific Journal of Cancer Prevention, 2021. 22(4): p. 1157-1163.
27. Sotiriou, C., et al., Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. Journal of the National Cancer Institute, 2006. 98(4): p. 262-272.
28. O'Malley, M.S., et al., The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening? American Journal of Public Health, 2001. 91(1): p. 49.
29. Mitchell, P.S., et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences, 2008. 105(30): p. 10513-10518.
30. Chen, X., et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research, 2008. 18(10): p. 997-1006.
31. Gilad, S., et al., Serum microRNAs are promising novel biomarkers. PloS one, 2008. 3(9): p. e3148.
32. Arefi, M., et al., Expression Analysis of Circulating miR-21 in Iranian Patients with Hereditary Colorectal Cancer. Medical Laboratory Journal, 2021. 15(2): p. 1-4.
33. Moridikia, A., et al., MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. Journal of cellular physiology, 2018. 233(2): p. 901-913.
34. Jin, X.-H., S. Lu, and A.-F. Wang, Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC cancer, 2020. 20(1): p. 1-7.
35. Zhong, S., et al., Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 1993. 14(9): p. 1821-1824.
36. Musilová, K. and M. Mráz, MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia, 2015. 29(5): p. 1004-1017.